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Convergent Recognition of the IgE Binding
Site on the High-Affinity IgE Receptor
X4CX2GPX4CX4 (Nakamura et al., 2001). IgE receptor
binding peptides of this class adopt an extended  hair-
pin conformation with a type I turn centered at residues
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for the structure and stability of the peptide.
The second family of peptides described that bind the
IgE receptor was selected initially from a naive peptideSummary
library of the form X2CX3CX2 (Nakamura et al., 2002).
Monomeric 9-mer peptides with the selected sequenceTwo structurally distinct classes of peptides were re-
motif X2CPX2CYX had weak affinity at best; however,cently identified by phage display that bind the high-
one peptide was found to undergo spontaneous conver-affinity IgE receptor, FcRI, and block IgE binding and
sion to a higher affinity disulfide-linked antiparallel di-subsequent receptor activation. Both classes adopt
mer. Subsequent introduction of a 3 residue “linker”highly stable structures in solution, one forming a 
sequence to make a 21 residue “single-chain dimer”hairpin, with the other forming a helical “zeta” struc-
form of the peptide and further optimization on phageture. Despite these differences, the two classes bind
resulted in a nanomolar peptide inhibitor. Peptides ofcompetitively to the same site on the receptor. Struc-
this second class adopt a stable structure composedtural analyses of both peptide-receptor complexes by
of two small antiparallel 310 helices connected by twoNMR spectroscopy and/or X-ray crystallography re-
disulfide bonds (Figure 1B). The backbone structure isveal that the unrelated peptide scaffolds have never-
nearly symmetric, with residues 1–9 adopting essentiallytheless converged to present a similar three-dimen-
the same structure, resembling the Greek letter zeta (),sional surface to interact with FcRI and that their
as residues 13–21, connected by a flexible linker, hencemodes of interaction share a key feature of the IgE-
the designation “zeta peptides” based on their three-FcRI complex, the proline/tryptophan sandwich.
dimensional structure. As for the hairpins, key positions
in the zeta peptide required for structure and function
Introduction were identified from analysis of peptide analogs both
by NMR and activity measurements. Again, the most
Molecules that prevent IgE from binding its high-affinity important residue for high-affinity receptor binding was
receptor, FcRI, have therapeutic potential in the treat- shown to be a proline, in this case Pro16 (Figure 1B).
ment of asthma and allergic disease. The anti-IgE anti- The structure of FcRI is comprised of two Ig-like
body Xolair (Omalizumab), recently approved for the domains, D1 and D2 (Garman et al., 1998, 2001). The
treatment of moderate-to-severe persistent asthma, crystal structure of the Fc portion of IgE in complex with
binds IgE and prevents IgE from binding to its receptors, FcRI shows an extensive interface involving interac-
thereby blocking IgE-mediated signaling on mast cells tions of both C3 domains of IgE with different parts
and basophils (Babu et al., 2001; Owen, 2002). Recently, of the receptor surface (Garman et al., 2000); one C3
two classes of peptides have been described that bind domain binds receptor residues fully contained within
the high-affinity IgE receptor (Nakamura et al., 2001, D2 (site 1), while the other interacts with residues at the
2002). These peptides were identified by sorting naive D1-D2 junction (site 2). Interestingly, the site 2 interac-
peptide phage display libraries for novel agents that tion is centered around a proline residue from IgE,
would bind the extracellular portion of the  chain of Pro426, which is buried between two tryptophan resi-
FcRI (FcRI). Although sorted only for binding the re- dues on the receptor. FcRI undergoes little change
ceptor, these peptides were also found to block IgE in conformation upon IgE binding. The peptides could
from binding and prevent downstream IgE-mediated interfere with IgE binding to its receptor either by direct
signaling events in basophils. The two classes are unre- competition, binding within (or overlapping) one or both
lated in primary sequence and adopt very different, but IgE binding sites on FcRI, or through an allosteric mech-
stable, tertiary structures in solution (Figure 1). Struc- anism.
tural analysis of how these peptides bind the high-affin- Herein, we investigate the molecular mechanism by
ity IgE receptor will be useful in the development of which peptides of the hairpin and zeta classes bind the
novel IgE antagonists. high-affinity IgE receptor. Structural analyses of both
The first family of phage-derived peptides described peptide-receptor complexes show that they indeed bind
that bind the high-affinity IgE receptor were selected within IgE binding site 2. Not only do the peptides com-
from a naive peptide library of the general form pete with IgE, but also with one another, utilizing a com-
mon interaction motif. Thus, although there is no similar-
ity in sequence or secondary structure between the two*Correspondence: star@gene.com
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Figure 1. Sequences and Structures of Zeta and Hairpin Peptides
Used in This Study
(A) Primary sequences and IgE-receptor binding affinities of the
peptides used for structure and function studies. Note that the se-
quences of the two zeta peptides used for NMR (e117) and X-ray
(e131) structural analyses differ only in the flexible “linker” and
C-terminal regions; the 3D structures of the core regions of the
two peptides are indistinguishable (Nakamura et al., 2002). The IC50
values are from cell-based binding inhibition assays measuring 125I-
IgE binding to CHO-3D10 cells that express the human FcRI sub-
unit as reported previously (Nakamura et al., 2001, 2002).
(B) Solution structure of e131 showing the functionally important
proline, Pro16, in red (PDB 1KCO [Nakamura et al., 2002]).
(C) Solution structure of IGE06 showing the functionally important
proline, Pro9, in red (PDB code 1JBF [Nakamura et al., 2001]).
Figure 2. Hairpin and Zeta Peptides Compete for Binding to FcRI
(A) Competitve displacement of phage displaying a hairpin peptidepeptide classes, they have nevertheless converged to
from binding immobilized FcRI-Fc measured by ELISA (see Exper-present a similar three-dimensional interaction surface
imental Procedures). Data are shown for hairpin peptide IGE06for receptor binding that partially mimics the natural
(squares) and zeta peptide e109 (circles). IC50 values from the fittedligand IgE. curves are 3.6 and 1.4 M, respectively.
(B) Competitive binding of peptides in a SPR assay. Individual pep-
tides were first injected at a predetermined saturating concentrationResults
for comparison with a mixture of the two peptides at equal concen-
tration. The relative molar amounts (RMA) of peptides bound canCompetition between Zeta and Hairpin Peptides
be compared by normalizing the SPR signal (RU) by the respective
for FcRI Binding molecular weights of the peptides: RMA(e111)  0.0216 versus
In order to test whether peptides from the two classes RMA(IGE10)  0.0223.
would compete with one another for receptor binding,
a zeta peptide was examined for whether it could block receptor with affinities of 0.8 and 0.3 M, respectively
phage displaying a representative hairpin peptide from (Nakamura et al., 2001, 2002). In surface plasmon reso-
binding immobilized FcRI. Figure 2A shows that not nance (SPR) binding experiments using saturating pep-
only does a hairpin peptide compete with hairpin-phage tide concentrations, a similar molar amount of each pep-
for FcRI binding as expected, but also zeta peptide tide, based on normalized response units, was found
e109 competes with hairpin-phage for FcRI binding to bind to immobilized FcRI. A mixture of the two
with an IC50 of 1.4 M, similar to that measured pre- peptides, each at saturating concentrations, did not
viously for blocking IgE binding to FcRI expressed on yield significantly higher signal than the zeta peptide
a cell surface (IC50  1.1 M [Nakamura et al., 2002]). alone, indicating that the two classes of peptide com-
To further test whether the peptides themselves, in the pete for overlapping sites on the receptor (Figure 2B).
absence of phage, are sufficient to compete with one
another for receptor binding, representative peptides Receptor Mutagenesis Localizes the Zeta
with similar affinities were chosen from each structural Peptide Binding Site
class; hairpin peptide IGE10 (Mr  1745 kDa) and zeta Alanine mutants of FcRI were expressed on phage
and tested for binding to zeta peptide e131. The assaypeptide e111 (Mr  2265 kDa) have been shown to bind
IgE Receptor-Peptide Inhibitor Complexes
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to interact with the receptor. Thus, the mutations that
disrupt peptide binding map to the tryptophan patch in
IgE binding Site 2 (Figure 3B).
NMR Analysis of a Zeta
Peptide-Receptor Complex
13C/15N-labeled zeta peptide was obtained by expression
of an e117/Z-domain fusion protein in E. coli followed
by trypsin cleavage and purification of the 23 residue
zeta peptide (Nakamura et al., 2002). This peptide was
shown previously to bind FcRI and block IgE binding (80
nM IC50 [Nakamura et al., 2002]). Complete resonance
assignments were obtained for the free peptide, but
assignment of the FcRI-bound peptide was compli-
cated by severe line-broadening of peaks from residues
buried at the protein-peptide interface. Nevertheless,
unambiguous assignments could be obtained for a ma-
jority of the peptide resonances based on analysis of a
3D 1H/1H/13C-edited NOESY (Table 1).
A large variation in linewidths was observed for the
peptide resonances in the receptor-bound complex,
with those from residues at the termini and in the GGH
“linker” being sharper and significantly more intense
than those from the rest of the peptide. These sharper
peaks also underwent minimal changes in chemical
shift, consistent with this group of residues being of
minimal importance for receptor binding (as determined
from previous analysis of peptide analogs [Nakamura
et al., 2002]). In contrast, significant chemical shift per-
turbations were observed for many of the peaks from
residues contained within the “disulfide-bonded core”
of the peptide; the most dramatic changes in chemical
shift upon receptor binding are seen for the 1H reso-
nances of Pro16 (H, H, H, and H all shift upfield
1.7–3.1 ppm; Table 1). Shifts of this magnitude experi-
enced by all protons within a proline ring can only be
explained if the proline lies packed between two aro-Figure 3. Alanine Mutation of FcRI Localizes the Peptide Binding
Region matic rings in the protein-peptide complex (Case, 1995).
Coincidentally, in the crystal structure of the Fc fragment(A) ELISA performed as described in the Experimental Procedures.
Data for the wild-type receptor (diamonds) and the two mutants of IgE in complex with FcRI, Pro426 of IgE is found
W87A (squares) and W110A (circles) are shown with IC50 values of “sandwiched” between two tryptophans, Trp87 and
0.86, 180, and 39 M, respectively. Trp110, on the receptor (Garman et al., 2000).
(B) Ribbon diagram of FcRI from the structure of the IgE–receptor
Inspection of a 13C-edited, 12C-filtered NOESY spec-complex (PDB code 1F6A [Garman et al., 2000]). The backbone of
trum showed intermolecular NOEs between isotopicallyreceptor residues involved in IgE binding Site 1 is colored green,
labeled peptide and unlabeled protein. Thirty-eight inter-while that outlining Site 2 is colored blue. Side chains are shown only
for those residues that were tested as individual alanine mutants. molecular NOEs were assigned involving protons from
Residues that show a 	6- or 	40-fold decrease in peptide binding residues Val1, Gln2, Pro4, Leu14, and Val18 on the pep-
when substituted by alanine are colored orange or red, respectively. tide. Peptide residues Val1, Leu14, and Val18 showed
NOE crosspeaks to at least two distinct aromatic groups
on the receptor. Furthermore, peptide residues Val1,used for evaluating the effects of these mutations re-
quires the mutant receptor to be capable of binding IgE; Gln2, and Pro4 showed NOEs to a pair of peaks resonat-
ing at 0.75 and 0.73 ppm, which were assigned to a pairthe ability of the peptide to inhibit this binding is then
measured to establish the extent to which the receptor of methyl groups from the receptor based on crosspeak
intensity and resonance frequency. Receptor contactsmutation affects peptide binding. Substitution of either
Trp87 or Trp110 by alanine was found to reduce zeta involving aromatic and methyl-containing side chains
are consistent with binding near IgE binding site 2 aspeptide binding to FcRI by 210- and 45-fold, respec-
tively (Figure 3A). Individual mutation of Arg111, Trp113, suggested by the mutagenesis data discussed above.
The only methyl groups in the vicinity of site 2 on theor Tyr160 to alanine also showed a significant decrease
in binding (13-, 7-, and 25-fold, respectively; data not receptor are those of Leu158, allowing tentative assign-
ment of the intermolecular methyl NOEs mentionedshown). However, alanine mutation of Lys117, Trp130,
Leu132, Trp156, Gln157, and Leu158 resulted in only a above. The pattern of intramolecular peptide NOEs ob-
served indicates that the zeta peptide does not undergosmall or insignificant change in the ability of the peptide
Structure
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Table 1. Resonance Assignments for Free and Receptor-Bound Zeta Peptide e117
Residue HN; 15N H; 13C H; 13C H; 13C H; 13C
1 Val 3.79; 61.1 2.10; 32.7 0.90; 20.3
3.94; 60.7 2.31; 33.1 0.92; 19.9
1.15; 20.1
1.24; 20.6
2 Gln 8.61; 124.3 4.41; 55.7 1.94, 2.01; 29.5 2.30*; 33.7 : 6.77, 7.43; 112.1
8.75; 125.0 4.55; 55.3 1.97*; 29.5 2.27, 2.33; 33.6 6.79, 7.39; 111.9
3 Cys 8.38; 121.8 4.88; 53.2 3.10*; 40.7
8.89; 122.2 4.33; 54.5tent na
4 Pro 4.33; 62.4 1.28, 2.24; 32.7 1.69, 1.83; 27.8 3.33, 3.57; 50.6
4.35; 62.5 1.22, 2.21; 32.6 1.71, 1.93; 27.5 na
5 His 8.69; 118.7 4.40; 59.4 3.29, 3.37; 28.3
8.78; 120.4 4.44; 59.5 3.33, 3.42; 28.2
6 Phe 7.84; 113.9 4.34; 59.0 2.97, 3.27; 37.1
8.02; 114.5 4.28; 59.3 2.81, 3.19; 36.4
7 Cys 7.50; 117.8 4.19; 55.0 1.86, 2.10; 36.2
7.23; 118.1 4.25; 54.9 na
8 Tyr 7.91; 118.2 4.85; 57.6 2.54, 3.46; 38.6
8.00; 118.9 4.87; 57.8 2.60, 3.53; 38.5
9 Val 7.09; 117.0 4.32; 61.6 2.13; 33.2 0.87; 19.8, 0.91; 21.2
7.10; 118.3 4.33; 61.7 2.13; 33.2 0.87; 20.1, 0.93; 21.2
10 Gly 8.47; 111.7 3.89, 4.07; 45.6
8.52; 112.1 3.92, 4.11; 45.4
11 Gly 8.31; 109.0 3.84, 3.89; 45.5
8.27; 108.7 3.88*; 45.5
12 His 8.00; 117.2 4.61; 54.8 3.07, 3.19; 29.4
8.01; 117.2 4.60; 54.4 3.02*; 29.2
13 Ala 8.29; 124.5 4.28; 52.5 1.24; 18.8
8.36; 124.7 4.31; 52.2 1.13; 18.2
14 Leu 8.17; 120.5 4.38; 55.5 1.66, 1.71; 42.6 1.62; 27.0 0.83; 23.4, 0.89; 25.2
8.27; 119.7 4.40; 56.4 1.82, 1.94; 43.9 1.84; 27.2 0.98; 23.8, 1.06; 24.8
15 Cys 7.80; 118.5 4.87; 53.8 3.21*; 40.9
7.66; 116.7 5.10; 53.8tent na
16 Pro 4.43; 63.2 1.85, 2.45; 32.7 2.00, 2.05; 27.9 3.56, 3.78; 50.6
2.66; 62.1 0.17, 0.43; 30.9 
1.09, 
0.66; 24.8 1.07, 1.87; 48.7
17 Asp 8.50; 121.5 4.43; 57.9 2.69, 2.74; 40.1
na 4.24; 57.8 2.76*; 40.6
18 Val 8.08; 117.1 4.05; 63.7 2.21; 31.3 0.91; 20.1, 0.91; 20.5
na 4.08; 63.0 2.35; 31.1 0.88; 20.0, 1.05; 20.8
19 Cys 7.99; 115.5 4.49; 54.7 2.10, 2.28; 36.2
7.50; 115.7 4.46; 54.8 2.22, na; 35.9
20 Tyr 8.04; 119.0 4.84; 57.7 2.76, 3.39; 38.9
7.84; 118.9 4.96; 57.1 2.79, 3.40; 38.9
21 Val 7.36; 119.0 4.15; 62.7 2.10; 32.7 0.97; 21.0, 1.01; 20.7
7.33; 119.0 4.18; 62.6 2.13; 32.7 1.00; 21.0, 1.04; 20.6
22 Gly 8.61; 113.4 3.90, 3.95; 45.6
8.68; 113.8 3.93, 3.98; 45.5
23 Arg 7.65; 125.1 4.19; 57.0 1.70, 1.88; 31.5 1.54*; 27.2 3.12*; 43.5
7.66; 125.2 4.23; 56.9 1.73, 1.92; 31.5 1.58*; 27.3 3.17*; 43.4
Upper values are for the free peptide; lower values represent the FcRI-bound peptide; values shown in bold are those that differ by 0.15
ppm (1H), 0.6 ppm (13C), or 1.5 ppm (15N) between free and bound states. Asterisks indicate degenerate methylene protons. na indicates that
the peak is broadened sufficiently that the resonance cannot be assigned unambiguously. Tent indicates that the nuclei were assigned by
amino acid type, but the sequence-specific assignment is tentative, based on calculated chemical shifts in the complex; hence, the 13C1H
shifts for Cys3 and Cys15 represent the best assignment based on the available data, but are not assigned conclusively.
a significant change in conformation upon receptor peptide in the bound state (see Experimental Proce-
dures). A remarkable correspondence between the cal-binding. Taken together, these data suggest a qualita-
tive model for the zeta peptide-receptor complex, with culated and observed 1H shifts (Figure 4A) is seen for
the model of the zeta peptide-receptor complex shownPro16 packing between Trp87 and Trp110, and the N-ter-
minal portion of the peptide contacting Leu158. in Figure 4B, suggesting that this model represents a
good approximation of the peptide-receptor complexIn order to obtain a more quantitative description of
the complex, a model of the peptide based on the free structure.
structure (derived from the structure of PDB code 1KCN
[Nakamura et al., 2002]) was docked onto the receptor Crystal Structure of a Zeta
Peptide-Receptor Complexsuch that the proline face of the peptide would approach
the tryptophan patch in site 2. The docked model was Attempts to obtain suitable crystals of peptide-receptor
complex using the same peptide, e117, used for NMRrefined based on optimizing the agreement between
the calculated and observed 1H chemical shifts of the studies described above were unsuccessful. However,
IgE Receptor-Peptide Inhibitor Complexes
1293
are made by peptide residues Pro4 and Phe6, which
lie in a shallow pocket lined by Trp87, Trp113, Trp156,
Leu158, and Tyr160 of the receptor (Figure 5C). Peptide
and protein bury 430 A˚2 each in the interface, which
is predominantly hydrophobic in nature. A potential salt
bridge is formed between Asp17 on the peptide and
Lys18 on the protein, likely accounting for the impor-
tance of a negative charge in this vicinity as seen from
mutational analysis of e131 (Nakamura et al., 2002).
An overlay of the crystal structure and the NMR-based
model for the zeta peptide-receptor complexes, based
on superposing only the receptor coordinates, shows
that both approaches identified equivalent modes of
binding to site 2 for the two related zeta peptides e117
and e131 (Figure 5C; and see Figure 1A). Significant
differences are seen only in the conformations of the
linker and terminal regions of the peptides, which is
not surprising given that these regions differ in primary
sequence in the two complexes, were found to be flexi-
ble in solution, and participate in crystal packing con-
tacts (see Experimental Procedures). Notably, the corre-
spondence between the calculated shifts for Pro16 of
e131 based on the crystallographically defined coordi-
nates and the observed shifts for Pro16 of e117 in the
complex in solution is good, with all proton resonances
being predicted to be shifted upfield from random coil
chemical shift values by 	1 ppm (Figure 4A); the differ-
ences in the exact values calculated from the different
complex structures highlight the exquisite sensitivity of
chemical shift and their dependence on precise distance
and orientation with respect to aromatic rings. Thus,
the nearly rigid-body docking procedure based on 1H
chemical shifts is valid for this complex, since neither
component undergoes significant conformational change
upon binding.
NMR Analysis of a Hairpin
Peptide-Receptor Complex
13C/15N-labeled IGE32 hairpin peptide was produced
similarly to the zeta peptide as a fusion protein secreted
Figure 4. NMR Analysis of e117 Zeta Peptide-Receptor Complex from E. coli, except that CNBr cleavage was used to
remove the fusion partner since the peptide contained(A) Agreement between calculated and observed 1H chemical shifts
in the complex (black circles; rms error  0.04 ppm, R  0.9989). a single methionine residue at the C terminus. Previous
Also plotted are the 1H chemical shifts calculated for Pro16 from studies showed that the C-terminal residue could be
the coordinates of the e131-FcRI crystal structure (red symbols, modified to other hydrophobic residues without loss of
which differ for each of the four complexes in the asymmetric unit;
binding (Nakamura et al., 2001), and thus, as expected,see text).
IGE32, ending in a lactone following cleavage, shows(B) Superposition of 20 models of zeta peptide-receptor complex
binding affinity comparable to IGE06 (Nakamura et al.,derived from docking and refinement based on 1H chemical shifts
(average rms error  0.041  0.005 ppm). 2001) (1 M IC50; Figure 1A). Resonance assignments
were obtained for the free and FcRI-bound peptide
(Table 3). Striking changes in 1H chemical shift values
were observed for resonances of Pro9 and Thr6, which
shift upfield by 1.7–3.2 ppm upon binding the receptor.the complex of zeta peptide e131 and FcRI (32 nM
IC50 [Nakamura et al., 2002]) was crystallized with four As discussed above for the zeta peptide, these extreme
changes in chemical shift can only be explained ifcomplexes in the asymmetric unit and diffracted to 3.0 A˚
resolution (Table 2). The structure was solved by molec- these nuclei pack closely against aromatic rings in the
complex.ular replacement with the coordinates for the free recep-
tor (1F2Q [Garman et al., 1998]) (see Experimental Proce- The pattern of intramolecular NOEs observed indi-
cates that the peptide maintains its hairpin structuredures); clear electron density for the bound peptide was
visible after rigid body refinement (Figure 5A). The zeta when bound to the receptor. A total of 40 intermolecular
NOEs were assigned involving resonances from peptidepeptide indeed binds the high-affinity IgE receptor in
IgE binding site 2 with Pro16 packed between Trp87 residues Asn1, Leu2, Pro3, Thr6, Val13, and Met15, in-
cluding NOEs between peptide residues Val13 andand Trp110 of the receptor (Figure 5). Further contacts
Structure
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Table 2. Data Reduction and Refinement Statistics for e131-FcRI Complex
Resolution (A˚) Nmeasa Nrefb Completec I/ Rmerged Rworke Rfreef
30.0–6.44 16370 3151 100.0 26 0.031 0.31 0.43
6.44–5.12 16879 3143 100.0 26 0.043 0.26 0.28
5.12–4.48 16715 3098 98.0 26 0.049 0.25 0.32
4.48–4.07 16578 3109 98.4 23 0.059 0.26 0.32
4.07–3.78 15543 3078 97.5 16 0.091 0.28 0.32
3.78–3.56 14518 3087 97.8 11 0.150 0.30 0.36
3.56–3.38 13692 3050 96.6 6.2 0.228 0.33 0.35
3.38–3.23 13026 3064 97.0 4.0 0.343 0.35 0.36
3.23–3.11 12732 3049 96.5 2.8 0.499 0.37 0.41
3.11–3.00 12550 2644 83.7 2.0 0.686 0.39 0.44
30.0–3.00 148963 30473 96.5 7.4 0.068 0.29 0.35
Refinement resolution (A˚) 30.0–3.0
Number of reflections 30473
R value 29.5%
Rfree 35.0%
R value (all) 30.6%
Rmsd bond distances (A˚) 0.008
Rmsd bond angles () 1.4
Rmsd dihedral angles () 26
Rmsd improper dihedral angles () 1.0
Number of atoms 6744
Number of atoms occupancy zero 156
Number of amino acid residues 746
Number of sugar residues 46
Number of waters 0
Number of sulfate ions 2
Number of citrate ions 2
Rmsd B factors (A˚2)
Bond 2.5
Angle 4.4
Rmsds versus reference receptor 0.01, 0.01, 0.01
(A˚) (NCS)
Rmsds versus reference receptor 1.1, 1.6, 2.1
(A˚) (non-NCS)
Rmsds versus reference e131 (A˚) 1.1, 1.6, 1.6
(non-NCS)
a Nmeas is the total number of observations measured.
b Nref is the number of unique reflections measured at least once.
c Complete is the percentage of possible reflections actually measured at least once.
d Rmerge  ||I| 
 |I	||/|I	|, where I is the intensity of a single observation and I	 the average intensity for symmetry equivalent
observations.
e Rwork  |Fo 
 Fc|/|Fo|, where Fo and Fc are observed and calculated structure factor amplitudes, respectively.
f Rfree  Rwork for 968 reflections sequestered from refinement, selected at random.
Met15 and a pair of methyl groups from the protein. As Discussion
before, these were tentatively assigned to Leu158 of the
receptor, giving an orientation of peptide on protein Peptides Utilize a Proline Sandwich as Typified
by the IgE-FcRI Complexsuch that Pro9 would pack between Trp87 and Trp110,
while the ends of the hairpin would lie near Leu158. A Herein we have shown that FcRI binding peptides of
the zeta and hairpin classes compete with one anotherdocking protocol similar to that used for the zeta com-
plex was employed to orient the hairpin peptide onto for receptor binding. Mutagenesis experiments map the
peptide binding site to the tryptophan patch in IgE bind-site 2 of the receptor (see Experimental Procedures).
Refinement of this model based on optimizing the agree- ing site 2. Previous analysis of peptide variants showed
that the most important residue for receptor binding byment between calculated and observed 1H chemical
shifts of the peptide resulted in the model shown in both classes was a proline, Pro16 and Pro9 for zeta
(Nakamura et al., 2002) and hairpin (Nakamura et al.,Figure 6. The excellent correspondence between the
calculated and observed chemical shifts indicates that 2001) peptides, respectively. Substitutions of these resi-
dues by alanine results in complete loss of detectablethis model represents a close approximation of the
structure of the hairpin-receptor complex (Figure 6A). binding, despite the fact that the structures of the pep-
tides were not compromised by this modification. NMRIndeed, as was found for the zeta peptide complex, a
proline on the peptide, Pro9, is sandwiched by Trp87 analysis of the receptor-bound peptides shows that the
important proline residues from each peptide class ex-and Trp110 of the receptor. Thr6 and Val13 lie in the
adjacent shallow pocket, which is capped by additional perience remarkably large chemical shift perturbations
upon receptor binding, indicating that in both peptide-hydrophobic interactions provided by Leu2 of the
peptide. receptor complexes a proline ring packs against aro-
IgE Receptor-Peptide Inhibitor Complexes
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Figure 5. Crystal Structure of e131 Zeta Peptide-Receptor Complex
(A) Stereo view of the a-weighted, simulated annealing omit map (2mFo 
 DFc) electron density within 2 A˚ of a peptide atom, contoured at
1.0 rmsd (green). To create this map, all four zeta peptides in the asymmetric unit were omitted during annealing and phase calculation.
Carbon atoms of the peptide (chain W) are blue, and carbon atoms of the receptor (chain A) are white. Note that Pro16 from the peptide lies
between side chains of two tryptophan residues on the receptor (Trp87 and Trp 110).
(B) Overlay of the four peptide-receptor complexes in the asymmetric unit superimposed on the backbone coordinates of each receptor.
(C) Overlay of representative models of the zeta e131 and e117 peptide-receptor complexes evaluated by crystallography (blue) and NMR
(green), respectively. The structures were superimposed based only on receptor coordinates. The receptor backbone ribbon is colored white
for both the crystallography and NMR models. Selected side chains from the peptide and receptor that are mentioned in the text are labeled.
matic rings. NMR and crystallographic studies reveal Proline/Tryptophan Interactions Are Common
in Protein-Protein Interfacesthat, indeed, Pro16 of the zeta class and Pro9 of the
hairpin class intercalate between Trp87 and Trp110 of While phage-derived peptides could have been selected
for binding anywhere on the surface of the IgE receptor,the receptor, similar to the arrangement seen for Pro426
of IgE in the IgE-FcRI complex (Figure 7A) (Garman two distinct classes of peptides were identified that both
bind the tryptophan-rich patch at the D1/D2 junction.et al., 2000). Such a proline/tryptophan sandwich ap-
pears to be a conserved feature of all immunoglobulin Interestingly, conserved surface-exposed tryptophan
residues can be predictive of protein binding sites (MaFc receptor complexes (Radaev et al., 2001; Sonder-
mann et al., 2000; Sondermann and Oosthuizen, 2002); et al., 2003), where frequently tryptophan is found in
contact with proline residues (Glaser et al., 2001). Inhere we show that peptides that share no similarity to
an immunoglobulin fold share a common feature in their particular, SH3 domains, EVH1 domains, WW domains,
and profilin all take advantage of proline/tryptophan in-respective Fc receptor binding interfaces.
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Table 3. Resonance Assignments for Free and Receptor-Bound Hairpin Peptide IGE32
Residue H; 13C H; 13C H; 13C H; 13C
1 Asn 4.34; 52.6 2.86, 2.97; 38.1
4.23; 52.7 2.82, 2.92; 38.9
2 Leu 4.68; 53.2 1.61*; 41.6 1.71; 27.0 0.95; 23.3, 0.96; 25.1
4.89; 52.5 1.24, 1.56; 42.3 1.73; 26.8 0.72; 25.7, 1.09; 24.0
3 Pro 4.47; 63.0 1.89, 2.25; 32.2 2.05*; 27.3 3.66, 3.86; 50.5
4.71; 62.7 2.39, 2.58; 27.7 2.05*; 27.3 na
4 Arg 4.46; 56.1 1.86, 1.93; 31.0 1.65, 1.73; 27.2 3.25*; 43.3
4.17; 57.6 1.97, 2.09; 30.5 1.85*; 27.5 3.24*; 42.7
5 Cys 5.66; 55.5 2.69, 3.11; 47.6
(5.99; 54.3**) (2.34; 3.11; 49.7**)
6 Thr 4.56; 60.8 4.05; 71.6 1.19; 21.2
3.89; 60.8 3.50; 69.7 
0.54; 15.2
7 Glu 3.88; 56.3 0.94, 1.61; 29.5 1.43, 1.77; 29.5
4.12; 57.3 1.97, 2.09; 31.9 2.22, 2.39; 35.4
8 Gly 3.75, 4.37; 44.5
(4.00, 4.80; 45.1**)
9 Pro 4.04; 64.2 0.80, 1.87; 31.0 1.49, 1.73; 26.7 3.33, 3.42; 49.3
1.90; 62.0 
1.32,
0.42; 28.8 
1.25,
0.80; 24.3 0.12, 1.71; 47.3
10 Trp 4.90; 55.8 3.13, 3.52; 28.3
4.74; 56.0 2.94, 3.52; 27.2
11 Gly 3.81, 4.59; 44.1
(3.92, 4.78; 42.9**)
12 Trp 4.85; 57.7 3.15*; 30.0
4.73; 58.6 3.18, 3.26; 29.5
13 Val 4.43; 61.6 2.09; 34.2 0.96; 20.9, 0.97; 20.7
4.73; 59.6 2.22; 35.3 1.07; 19.7, 1.22; 21.0
14 Cys 5.42; 55.0 2.91, 3.03; 46.2
(5.89; 54.6**) (2.94, 3.07; 47.4**)
15 Met 4.33; 55.2 1.94, 2.12; 37.6 3.67*; 61.2
4.36; 54.5 1.41, 1.81; 37.8 3.30, 3.42; 60.7
Upper values are for the free peptide; lower values represent the FcRI-bound peptide; values shown in bold are those that differ by 0.15
ppm (1H), 0.6 ppm (13C), or 1.5 ppm (15N) between free and bound states. * indicates degenerate methylene protons. na indicates that the peak
is broadened sufficiently that the resonance cannot be assigned unambiguously. **Peaks for Cys5/Cys14 and Gly8/Gly11 could be assigned
by amino acid-type, but not sequence-specifically in the FcRI-bound state, thus the frequencies given for Cys5, for example, might actually
be switched with those for Cys14, and similarly for Gly8 and Gly11. HN resonances were not assigned in the bound state, as most were too
broad to obtain adequate correlations.
teractions at the core of their respective protein-protein same space on the receptor as those of Val13 and Thr6
of the hairpin in their respective receptor complexesinterfaces (Huang et al., 2000; Kay et al., 2000; Zarrinpar
and Lim, 2000). In all of these cases, not only do the (Figure 7). This results in Trp87 of FcRI being fully buried
within each peptide-receptor complex, being packed byproline and tryptophan rings show good van der Waals
packing, but also the backbone carbonyl group of the a proline on one side and hydrophobic side chains from
the peptide on the other. Indeed the overall shapes ofamino acid preceding the proline by two residues forms
a hydrogen bond with the tryptophan indole nitrogen the zeta and hairpin peptide’s receptor interaction sur-
faces are surprisingly similar (Figure 7C). Each peptide(Huang et al., 2000). An analogous interaction is seen
in the case of the zeta peptide-IgE receptor complex, provides a hydrophobic groove into which Trp87 can
pack, lined by either disulfide bonds of the zeta peptidewith the carbonyl of Leu14 forming a hydrogen bond with
Trp110. Such an interaction is not apparent however in or the conserved glycine residues (Gly8 and Gly11) of
the hairpin peptide where, for example, the Gly8Ala mu-the hairpin peptide complex, although the side chain of
peptide residue Glu7 may provide additional favorable tation leads to a 160-fold loss in receptor binding (Naka-
mura et al., 2001). Thus, while the peptide scaffolds arecontacts, either through hydrogen bonding with the in-
dole of Trp110 or by forming a salt bridge with Arg111 entirely different (one hairpin, one helical), they present
similar three-dimensional surfaces for binding receptor,of the receptor.
not unlike that seen for the multiple diverse natural pro-
teins that bind a common site on the Fc region of IgGStructurally Distinct Peptides Present
(DeLano et al., 2000).a Common Binding Motif
In contrast, IgE does not make contacts in the hy-The proline/tryptophan sandwich is not the only interac-
drophobic pocket neighboring the proline/tryptophantion in common between the zeta and hairpin peptides.
sandwich on the receptor (Figure 7A). Instead, IgE re-In both cases, they also contact an adjacent shallow
cruits high-affinity binding for its receptor by makinghydrophobic pocket on the receptor surface. Three-
additional contacts remote from this area in IgE bindingdimensional superposition of the receptor in the two
“site 1” located within the D2 domain of the receptor.peptide-receptor complexes shows that the position of
residues Pro4 and Phe6 of the zeta peptide occupy the Restricting the size of the peptides to 100-fold smaller
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450 mM NaCl) until UV absorbance at 280 nm was reduced to zero.
IgE receptor was eluted by washing with five column volumes of
elution buffer (50 mM sodium phosphate [pH 6.0], 500 mM NaCl, 5
M urea). Fractions containing IgE receptor as analyzed by SDS-
PAGE were pooled and concentrated. Protein was then loaded onto
a Sephadex-75 size exclusion column (Amersham Pharmacia Bio-
tech) preequilibrated with 50 mM sodium phosphate (pH 6), 450 mM
NaCl. Protein purity after size exclusion was 	95% as analyzed by
SDS-PAGE. Typical yield of IgE receptor was 1–2 mg/l of infected
cells. The IgE receptor is heavily glycosylated, with an average mo-
lecular mass of 30 kDa, while the polypeptide molecular weight
alone is 20 kDa.
Phage ELISA Competition
Oligonucleotide-directed mutagenesis was used to modify a
phagemid vector, pH0753, for display of the hairpin peptide NLP
RCTEGPWGWVCMAAD on the N terminus of the C-terminal domain
of the M13 gIII protein; peptide-phage were grown as described
previously (Lowman, 1998). FcRI-Fc (2 g/ml) was coated onto
Nunc Maxisorp plates (Nakamura et al., 2001). Three-fold serial dilu-
tions of peptides IGE06 or e109 were mixed with an equivalent
volume of phage (diluted to yield 40% saturation) and transferred
to the immobilized receptor plate. After 1 hr at room temperature,
the plates were washed and developed as described (Lowman,
1998). IC50 values were determined from a four-parameter curve fit
of the ELISA signal using Kaleidagraph.
Competitive Binding Experiments Using
Surface Plasmon Resonance
Binding of peptides to immobilized FcRI (residues 1–176) was
carried out as described previously (Nakamura et al., 2001) using a
BIAcore-2000 instrument (BIAcore, Inc., Piscataway, NJ). Briefly,
FcRI was immobilized using surface-thiol chemistry. Peptides
were injected in PBS containing 0.05% Tween-20 and 0.01% sodium
azide, at 25C. The amount of each peptide bound at steady state
was measured as the difference in surface plasmon resonance (SPR)
signal between the FcRI-coupled flow cell and a control flow cell
containing no immobilized protein.
Display and Mutagenesis of FcRI on Phage
DNA encoding human FcRI residues 1–176 was inserted intoFigure 6. NMR Analysis of IGE32 Hairpin Peptide-Receptor
phagemid vector pH0753 for display of the extracellular domain ofComplex
the  chain of the high-affinity IgE receptor at the N terminus of the
(A) Agreement between calculated and observed 1H chemical shifts
C-terminal domain of M13 gIIIp. Alanine substitutions of individual
in the complex (rms error  0.11 ppm; R  0.9967).
residues were incorporated into this FcRI phagemid using standard
(B) Superposition of 16 models of hairpin peptide-receptor complex
Kunkel mutagenesis (Kunkel et al., 1987), and phage displaying the
derived from docking and refinement based on 1H chemical shifts
IgE receptor were prepared as described (Sidhu et al., 2000). The
(average rms error  0.11  0.01 ppm).
display of wild-type and mutant FcRI phage was confirmed by
phage ELISA binding to immobilized IgE as described above.
than IgE requires that they exploit local interactions to Peptide Binding to FcRI Alanine Mutants
100–400 M soluble peptide was serially diluted and incubated withachieve high-affinity binding. The selection of these very
a previously titrated amount of wild-type or mutant FcRI-displayingstructurally diverse peptides that nevertheless bind to
phage. After a 30 min incubation period at room temperature, thethe same receptor site using very similar types of inter-
mixture was transferred to an IgE-coated 96-well immunoassay
actions represents an elegant example of convergent plate for 60 min at room temperature. Assay plates were washed,
evolution in vitro and identifies an additional contact incubated with horseradish peroxidase-conjugated anti-M13-
area not exploited by the natural ligand IgE. phage, and developed as described above. IC50 values for each
peptide were determined using a four-parameter curve fit in Kaleida-
graph. Each value was normalized for total binding. The mean ofExperimental Procedures
three separate assays is shown with error bars in Figure 3A. The
necessity of binding IgE for readout from this assay ensures thatIgE Receptor Expression and Purification
the protein is expressed and folded properly on the phage surface.DNA encoding the extracellular domain, residues 1–176, of human
All mutant proteins that were evaluated for peptide binding showedFcRI (Hakimi et al., 1990) was subcloned into the baculovirus
IgE binding affinities comparable to or within 10-fold that of thetransfer vector pAcGP67B (PharMingen), which was then cotrans-
wild-type receptor. Nonetheless, the observed impact of a givenfected with BaculoGold DNA (PharMingen) into Sf9 cells; recombi-
mutation on peptide binding will be independent of any effects thenant virus was isolated and amplified in Sf9 cells. For protein produc-
mutation has on IgE binding, since the IgE in this experiment is usedtion, Hi-5 (T. ni) cells were infected with recombinant viral stock and
only as a capture reagent.grown in shaker flasks for 72 hr at 27C in ESF 921 media (Expression
Systems LLC). Supernatants were collected and filtered through 0.2
m filters and then loaded onto a CNBr-Sepharose-linked (Phar- Generation of Isotopically Labeled Peptides
Hairpin and zeta peptides were produced in E. coli as fusion proteinsmacia) e117 peptide/Z-domain fusion column (see below). The col-
umn was washed with buffer (50 mM sodium phosphate [pH 6.0], to the Z-domain of protein A as described previously (Dennis et al.,
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Figure 7. Comparison of Three FcRI Complexes
(A) Stereoview of an overlay of the IgE complex crystal structure (purple) (1F6A [Garman et al., 2000]), e131 zeta peptide complex crystal
structure (blue), and IGE32 hairpin peptide complex model based on NMR analysis (yellow), superposed on receptor coordinates only. The
FcRI receptor structure is shown in white ribbon for all three complexes; side chains are shown for the receptor in the zeta peptide complex
only. The view shown is essentially the same as that in Figures 4B and 6B.
(B) Stereoview of an overlay of the backbone structures of zeta (e131) and hairpin (IGE32) peptides taken from their respective receptor
complex structures, rotated 90 relative to the view in (A), showing the receptor binding face of each peptide.
(C) Surface representation of hairpin (left) and zeta (right) peptide oriented as in (B) but not superposed for clarity.
2001) to facilitate isotopic labeling. Peptides were labeled using a growth media supplemented with 50 g/ml carbenicillin was inocu-
lated with E. coli strain 27C7 harboring the peptide/Z-domain ex-protocol and media described previously for the alkaline phospha-
tase induction system in E. coli (Reilly and Fairbrother, 1994). Briefly, pression plasmid. Cultures were grown at 30C in shaker flasks for
IgE Receptor-Peptide Inhibitor Complexes
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24 hr. Cells were harvested and then washed with 300 ml wash of 2D 1H/13C-HSQC, 2D CBCA(CO)NH, 2D 1H/13C-HCCH-TOCSY.
Resonances in the receptor-bound state were assigned by analysismedia for every 1 liter of cells to remove excess phosphate. Cells
were then resuspended in production media supplemented with 50 of 2D 1H/13C-HSQC and 3D 13C-edited NOESY (mixing time, 110 ms).
The resonances for the important Pro9 were extremely broad andg/ml carbenicillin and incubated in shaker flasks at 30C for an
additional 24 hr. Cells were harvested by centrifugation and placed hence did not show cross peaks in the 13C-edited NOESY spectrum,
and thus, assignment of these resonances was confirmed by analy-at 
20C for overnight storage.
Cells were thawed and combined with 40 ml of 20 mM Tris (pH sis of a 2D 1H/13C-HSQC spectrum acquired on a sample prepared
with 13C-Pro9 specifically labeled hairpin peptide (IGE06) generated8.0) for each 10 g of cell paste. Cells were stirred at 4C for 30
min to release protein from the periplasm. The sample was then by chemical synthesis (Nakamura et al., 2001). For the hairpin-recep-
tor complex, the 13C-F1-edited, 12C-F3-filtered NOESY spectrum wascentrifuged at 20,000 g to remove insoluble material. The superna-
tant was loaded onto a Q-Sepharose Fast Flow column (Amersham significantly less sensitive than the 13C-edited NOESY in detecting
the same NOE crosspeaks, and thus, intermolecular NOEs werePharmacia Biotech) and eluted with a 0–500 mM NaCl gradient in
the presence of 20 mM Tris (pH 8.0). Fractions containing protein assigned from the 13C-edited NOESY spectrum as those peaks be-
tween known peptide resonances and a 1H frequency not coincidentwere pooled and dialyzed against H2O. The samples were then ly-
ophilized and resuspended in 1–2 ml of 20 mM Tris (pH 8), 500 mM with any peptide frequency.
NaCl. The protein was loaded onto a Sephadex-75 size exclusion
column (Amersham Pharmacia Biotech) preequilibrated with 20 mM Chemical Shift Refinement
Tris (pH 8.0), 500 mM NaCl. Protein purity after size exclusion was The zeta and hairpin peptides were docked manually into IgE binding
	95% as analyzed by SDS-PAGE. The yields of peptide/Z-domain site 2 of FcRI using coordinates derived from the free structures
fusion proteins were approximately 20 mg/l and 40 mg/l for hairpin of related peptides (PDB codes 1KCN [Nakamura et al., 2002] and
and zeta peptides, respectively. 1JBF [Nakamura et al., 2001] for zeta and hairpin peptides, respec-
The zeta peptide was cleaved from the Z-domain by addition of tively) and from the crystal structure of the IgE/FcRI complex
1 mg of trypsin to 80 mg of fusion protein in cleavage buffer (PBS  (PDB code 1F6A [Garman et al., 2000]). The initial peptide place-
1.1 mM CaCl2) and allowed to react for 20 min. The peptide was ments were based on the assumption that the functionally important
then separated from the Z-domain using C18 HPLC. Fractions con- proline residues of the peptides, which experienced the most signifi-
taining the peptide (as assayed by mass spectrometry) were pooled cant 1H chemical shift perturbations upon receptor binding, would
and lyophilized. bind between Trp87 and Trp110 of the receptor, in approximately
For the hairpin peptide, 80 mg of hairpin/Z-domain fusion protein the same way as observed for Pro426 of IgE. The resulting peptide
was dissolved in 5 ml 96% formic acid and 5 drops of water. A orientations appeared consistent with intermolecular NOE correla-
spatula tip of CNBr was added; the reaction was stirred for 3 hr and tions observed between the 13C-labeled peptides and the unlabeled
quenched with 25 ml water and 2 ml TFA, stirred for 5 min, and then receptor; in particular, intermolecular NOEs between zeta peptide
rinsed into a lyophilization jar with 1:1 acetonitrile/water (25 ml) and residues Val1, Gln2, and Pro4 or hairpin peptide residues Val13 and
lyophilized. The sample was then put on a 10 g Sep-Pak Cartridge Met15, and an unidentified pair of receptor methyl groups could be
(Waters), washed with 10% aqueous acetic acid, and eluted with assigned tentatively to Leu158 of the receptor since these are the
80% acetonitrile/10% acetic acid in water. The sample was then only methyl groups in proximity to site 2. Calculation of the docked
diluted with water and lyophilized to give 30 mg white solid. The peptide 1H chemical shifts (O¨sapay and Case, 1991) using the pro-
Z-domain fusion partner was removed by passage over an IgG seph- gram SHIFTS 4.1 (X.P. Xu and D.A. Case, The Scripps Research
arose column (Pharmacia). The flow-through was then lyophilized, Institute, La Jolla, CA; http://www.Scripps.edu/case/qshifts/
desalted over a Sep-Pak Cartridge, and further purified by reverse qshifts.htm) showed good general agreement with the experimen-
phase HPLC to yield 1.5 mg pure peptide. tally observed chemical shifts, but also suggested that the manually
docked models could be refined further.
All the assigned aliphatic 1H chemical shift data were thereforeNMR Spectroscopy
All NMR spectra were acquired on a Bruker DRX-800 spectrometer incorporated as restraints (force constant  25 kcal·mol
1·ppm
1)
in a simple simulated annealing protocol, using the program AMBERequipped with a 5 mm inverse triple-resonance (1H/13C/15N) probe
with three-axis gradient coils. Proton chemical shifts were refer- 6.0 (http://amber.Scripps.edu/doc6/). For initial rounds of refine-
ment, the chemical shifts of prochiral methylene and methyl protonsenced to internal 3-(trimethyl-silyl)propane-1,1,2,2,3,3-d6-sulfonic
acid (DSS; Isotec); 13C and 15N chemical shifts were referenced indi- were averaged. The chemical shifts of all peptide protons were
back-calculated from the resulting models using SHIFTS 4.1 andrectly to DSS and liquid ammonia, respectively (Wishart et al., 1995).
Acquisition temperatures were evaluated to identify optimal condi- compared to the experimentally observed chemical shifts. In cases
where the chemical shifts of the prochiral protons were sufficientlytions to minimize peak linewidths and improve sensitivity. NMR
spectra for the zeta peptide e117-receptor complex were obtained different and the agreement between the calculated and observed
values was close, it was possible to make stereospecific assign-at 35C with a sample containing 300 M complex in PBS (pH 5.3),
either in 92% H2O/8% D2O or, after lyophilization and resuspension, ments that were incorporated into subsequent rounds of refinement.
In this way, stereospecific assignments were possible for Pro4 ,in “100%” D2O. NMR spectra for the hairpin peptide IGE32-receptor
complex were obtained at 20C with a sample containing 500 M Leu14 , and Pro16  and  protons of the zeta peptide, and Pro9
 and  and Val13  protons of the hairpin peptide.complex (in PBS [pH 5.3], lyophilized, and resuspended in “100%”
D2O). Slow exchange behavior was observed for most resonances Additional distance and dihedral angle restraints, derived from
those used to calculate the solution structures of the free peptides,of the zeta peptide complex, with significant broadening seen only
for residues at the interface. The hairpin peptide complex showed were incorporated into the refinement to ensure that the peptide
structures were maintained. In the case of the zeta peptide, theslow-to-intermediate exchange behavior throughout the molecule,
necessitating the lower acquisition temperature and high field spec- intrapeptide distance restraints corresponded to those used for cal-
culation of the free solution structure plus an additional 0.5 A˚, andtrometer for adequate sensitivity.
The resonances of free e117 peptide were assigned by standard were applied with a force constant of 32 kcal·mol
1·A˚
2. In the case
of the hairpin peptide, intrapeptide distance restraints correspond-analysis of 2D 1H/15N-HSQC, 3D 1H/15N-TOCSY-HSQC (mixing time,
90 ms), 2D 1H/13C-HSQC, 2D CBCA(CO)NH, and 2D 1H/13C-HCCH- ing to those used for calculation of the free peptide structure were
applied without modification using a force constant of 20 kcal·TOCSY (Cavanagh et al., 1995). Resonances in the receptor-bound
state were assigned by analysis of 2D 1H/15N-HSQC, 3D mol
1·A˚
2. In both cases, the dihedral angle restraints were equiva-
lent to those used for calculation of the free peptide structures and1H/15N-NOESY-HSQC, 2D 1H/13C HSQC, and 3D 13C-edited NOESY
(mixing time, 110 ms) (Cavanagh et al., 1995) due to the lower sensi- were applied with a force constant of 80 kcal·mol
1·rad
2.
The coordinates of the receptor were restrained to be nearly fixedtivity of J-correlated spectra for the32 kDa complex. Intermolecu-
lar NOEs were identified in a 13C-F1-edited, 12C-F3-filtered NOESY during the simulated annealing and subsequent restrained minimi-
zation calculations using a harmonic potential with a force constantspectrum (mixing time, 110 ms) (Zwahlen et al., 1997).
The resonances of free IGE32 peptide were assigned by analysis of 5 kcal·mol
1. For calculations with the zeta peptide, a weak har-
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monic potential (force constant  0.5 kcal·mol
1) was also used to 20 largest features in the final Fo 
 Fc electron density map, 10
are tentative water sites and 10 are associated with disorderedrestrain the disulfide-bonded core of the peptide (residues Cys3–
Tyr8 and Ala13–Tyr20). In the case of the hairpin peptide calcula- carbohydrate residues or protein segments that are difficult to model
accurately. Addition of 10 water oxygens had a negligible effect ontions, a similar weak harmonic potential (force constant  0.25
kcal·mol
1) was used in the initial rounds of refinement to restrain Rfree, and they were not retained.
The crystals are composed from tetramers of peptide-receptorthe entire peptide except residues Asn1, Leu2, Thr6, Trp10, and
Trp12; during the final rounds of refinement, these restraints were complexes arranged as dimers of dimers. Crystallographic symme-
try provides contacts between tetramers mediated mostly via carbo-removed.
Intermolecular NOEs between unambiguously assigned peptide hydrate attached to Asn42. Large “solvent” voids approximately
50 55 90 A˚ are presumably occupied by poorly ordered carbohy-protons and unassigned receptor methyl or aromatic protons were
assigned tentatively based on the docked and refined models. The drate. A noncrystallographic dimer is formed by a pseudo 2-fold
axis running between peptides bound to receptors “A” and “C,”tentatively assigned intermolecular NOEs were incorporated itera-
tively into the refinement calculations as upper-bound distance re- which provides peptide-peptide contacts of 130 A˚2 between pep-
tide “linker” regions. All four peptides contact their receptors acrossstraints of 5.8 and 5.0 A˚ (plus appropriate pseudo-atom corrections)
for the zeta and hairpin peptides, respectively, only if they were 430 A˚2, but the pseudo 2-fold also brings the neighboring receptor
in for some contact with the reference peptide. The details of theseclearly satisfied in the current models. In total, 17 and 22 intermolec-
ular distance restraints were included in the final simulated anneal- neighboring receptor contacts differ somewhat between peptides.
An additional pseudo 2-fold axis relates the dimers. Trp130, Tyr131,ing calculations for the zeta and hairpin peptides, respectively.
and Glu132 from receptors “A” and “B” (i.e., residues from the “site
1” region; Figure 3B) are involved in an interdimer contact on thisPurification and Crystallization of the e131-FcRI Complex
axis.Synthesized e131 peptide (Nakamura et al., 2002) was added to
purified IgE receptor at a ratio of 1.5:1. The complex was then
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